Australian University Rankings Guide

Bioorganic and Medicinal Chemistry (ERA Journal)

Bioorganic and Medicinal Chemistry is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Bioorganic and Medicinal Chemistry issns are issn1: 0968-0896 issn2: 1464-3391.

The fields covered by Bioorganic and Medicinal Chemistry as part of the evaluation of Australian university research excellence are:

Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)

Organic Chemistry Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:

- Advances in Protein Chemistry
- Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
- Archiv der Pharmazie
- Biological and Pharmaceutical Bulletin
- Current Molecular Medicine
- Current Protein and Peptide Science
- Free Radical Biology and Medicine
- Future Medicinal Chemistry
- Journal of Molecular Biology
- Molecular Medicine Reports
- Peptides
- Synlett: accounts and rapid communications in synthetic organic chemistry
- Tetrahedron Letters: the international journal for the rapid publication of all preliminary communications in organic chemistry
- The Federation of European Biochemical Societies (FEBS) Journal
- Vibrational Spectroscopy

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4